These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 15081114)

  • 1. Human artificial chromosomes containing chromosome 17 alphoid DNA maintain an active centromere in murine cells but are not stable.
    Alazami AM; Mejía JE; Monaco ZL
    Genomics; 2004 May; 83(5):844-51. PubMed ID: 15081114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of a novel human artificial chromosome vector for gene delivery.
    Katoh M; Ayabe F; Norikane S; Okada T; Masumoto H; Horike S; Shirayoshi Y; Oshimura M
    Biochem Biophys Res Commun; 2004 Aug; 321(2):280-90. PubMed ID: 15358173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CENP-B box is required for de novo centromere chromatin assembly on human alphoid DNA.
    Ohzeki J; Nakano M; Okada T; Masumoto H
    J Cell Biol; 2002 Dec; 159(5):765-75. PubMed ID: 12460987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An artificially constructed de novo human chromosome behaves almost identically to its natural counterpart during metaphase and anaphase in living cells.
    Tsuduki T; Nakano M; Yasuoka N; Yamazaki S; Okada T; Okamoto Y; Masumoto H
    Mol Cell Biol; 2006 Oct; 26(20):7682-95. PubMed ID: 17015481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in human artificial chromosome technology.
    Larin Z; Mejía JE
    Trends Genet; 2002 Jun; 18(6):313-9. PubMed ID: 12044361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of human artificial chromosome vectors by recombineering.
    Kotzamanis G; Cheung W; Abdulrazzak H; Perez-Luz S; Howe S; Cooke H; Huxley C
    Gene; 2005 May; 351():29-38. PubMed ID: 15837432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient assembly of de novo human artificial chromosomes from large genomic loci.
    Basu J; Compitello G; Stromberg G; Willard HF; Van Bokkelen G
    BMC Biotechnol; 2005 Jul; 5():21. PubMed ID: 15998466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficiency of de novo centromere formation in human artificial chromosomes.
    Mejía JE; Alazami A; Willmott A; Marschall P; Levy E; Earnshaw WC; Larin Z
    Genomics; 2002 Mar; 79(3):297-304. PubMed ID: 11863359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and epigenetic regulation of centromeres: a look at HAC formation.
    Ohzeki J; Larionov V; Earnshaw WC; Masumoto H
    Chromosome Res; 2015 Feb; 23(1):87-103. PubMed ID: 25682171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel human artificial chromosome vector provides effective cell lineage-specific transgene expression in human mesenchymal stem cells.
    Ren X; Katoh M; Hoshiya H; Kurimasa A; Inoue T; Ayabe F; Shibata K; Toguchida J; Oshimura M
    Stem Cells; 2005; 23(10):1608-16. PubMed ID: 16141362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction of YAC-based mammalian artificial chromosomes.
    Ikeno M; Grimes B; Okazaki T; Nakano M; Saitoh K; Hoshino H; McGill NI; Cooke H; Masumoto H
    Nat Biotechnol; 1998 May; 16(5):431-9. PubMed ID: 9592390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A minimal CENP-A core is required for nucleation and maintenance of a functional human centromere.
    Okamoto Y; Nakano M; Ohzeki J; Larionov V; Masumoto H
    EMBO J; 2007 Mar; 26(5):1279-91. PubMed ID: 17318187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of artificial chromosome centromeres in human and murine cells.
    Moralli D; Jefferson A; Valeria Volpi E; Larin Monaco Z
    Eur J Hum Genet; 2013 Sep; 21(9):948-56. PubMed ID: 23403904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional complementation of a genetic deficiency with human artificial chromosomes.
    Mejía JE; Willmott A; Levy E; Earnshaw WC; Larin Z
    Am J Hum Genet; 2001 Aug; 69(2):315-26. PubMed ID: 11452360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosome engineering: prospects for gene therapy.
    Grimes BR; Warburton PE; Farr CJ
    Gene Ther; 2002 Jun; 9(11):713-8. PubMed ID: 12032694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assembly of additional heterochromatin distinct from centromere-kinetochore chromatin is required for de novo formation of human artificial chromosome.
    Nakashima H; Nakano M; Ohnishi R; Hiraoka Y; Kaneda Y; Sugino A; Masumoto H
    J Cell Sci; 2005 Dec; 118(Pt 24):5885-98. PubMed ID: 16339970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in artificial chromosome technology.
    Monaco ZL; Moralli D
    Biochem Soc Trans; 2006 Apr; 34(Pt 2):324-7. PubMed ID: 16545105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human artificial chromosome (HAC) vector provides long-term therapeutic transgene expression in normal human primary fibroblasts.
    Kakeda M; Hiratsuka M; Nagata K; Kuroiwa Y; Kakitani M; Katoh M; Oshimura M; Tomizuka K
    Gene Ther; 2005 May; 12(10):852-6. PubMed ID: 15750614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human artificial chromosomes constructed using the bottom-up strategy are stably maintained in mitosis and efficiently transmissible to progeny mice.
    Suzuki N; Nishii K; Okazaki T; Ikeno M
    J Biol Chem; 2006 Sep; 281(36):26615-23. PubMed ID: 16837455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Making CENs of mammalian artificial chromosomes.
    Warburton PE
    Mol Genet Metab; 1999 Oct; 68(2):152-60. PubMed ID: 10527666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.